Skip to main content

Table 1 Characteristics of the patient cohort

From: Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation

 

JAK2

Age

Gender

WBC (109/L)

Hb (g/L)

Plt (109/L)

Blasts (%)

LDH (U/L)

 

mut

wt

 

m

f

     

CML (n = 10)

0

10

55

9

1

81.3

107

219

1

599

PV (n = 10)

8

2

56

4

6

12.4

133

370

0

259

ET (n = 10)

5

5

69

3

7

8.2

130,5

770

0

267

MF (n = 27)

14

13

67

12

15

10.1

104,5

376

0,5

431

Total

27

30

66

28

29

11.7

114

338

0

369

  1. Median values for age, WBC, Hb, Plt, Blasts, LDH. CML, Chronic myeloid leukemia, ET, essential thrombocythemia; Hb, hemoglobin; LDH, lactate dehydrogenase; MF, myelofibrosis; mut, positive for JAK2V617F; plt, platelet count; PV, polycythemiavera; WBC, white blood cell count; wt = negative for JAK2V617F.